Catch up on the latest news and updates from the Barts Cancer Institute, Queen Mary University of London. From important announcements to behind-the-scenes highlights, there’s always something new to explore. Scroll down to read the latest posts and see what we've been up to.

New research has revealed how melanoma cells that have become resistant to a type of targeted treatment called BRAF inhibitors can change the behaviour of nearby immune cells. The cancer cells release signals that encourage these immune cells, known as macrophages, to take on features that can support tumour growth.
Publications 16 November 2026

The international VOLGA clinical trial led by Professor Thomas Powles found that adding durvalumab and enfortumab vedotin to treatment around bladder-removal surgery improved survival for people who could not receive, or chose not to have, cisplatin chemotherapy.
Publications 3 November 2026

Cells soften and massage their nucleus to encourage the repair of broken DNA, research led by Professor Susana Godinho and team has discovered. Using cells grown in the laboratory, the researchers uncovered a previously unknown role for movement within cells in DNA repair. Their findings could point towards new ways to make cancer cells more sensitive to existing treatments that damage DNA or disrupt its repair.
Publications 28 October 2026

PharosAI – a partnership between Queen Mary University of London, King’s College London and two NHS Trusts, Guy’s and St Thomas, and Barts Health – has received Innovate UK funding to explore whether AI can predict complex biological information from routinely collected tissue data. The project, called DESTINY, will investigate whether AI can predict molecular information that would otherwise require costly and time-consuming tests.
Grants & Awards 15 October 2026

Dr Vivek Singh and team at Barts Cancer Institute, Queen Mary University of London, have been awarded more than £500,000 through Cancer Research UK’s Early Detection and Diagnosis Project Award to investigate whether artificial intelligence (AI) could help detect returning liver cancer earlier.
Grants & Awards 23 September 2026

Researchers have uncovered a mechanism that makes some cancer cells especially vulnerable to experimental drugs known as ATR inhibitors. The findings could support the development of tests to identify the patients most likely to benefit.
Publications 17 August 2026

Scientists have carried out one of the largest and most comprehensive studies to date of the genetic and clinical factors associated with cancer in British Bangladeshi and Pakistani people. The findings could help inform future efforts to make cancer screening and risk assessment more equitable.
Publications 7 August 2026

Scientists at Barts Cancer Institute, Queen Mary University of London, have uncovered an important way that cells keep their genes under control. The discovery could help explain one of the earliest molecular changes that occurs during the development of lung cancer. The study, published in Science Advances, reveals that a protein called LIMD1, which is frequently lost in lung cancer, plays a much bigger role in controlling gene activity than scientists previously realised. The findings uncover a previously hidden layer of gene regulation and may provide new insight into how normal cells begin to lose control during the earliest stages of cancer.
Publications 23 July 2026

Researchers have developed an artificial intelligence method that can detect signs of cancer by combining several different clues found in DNA fragments circulating in the blood. The method, developed by a team led by scientists at Barts Cancer Institute, Queen Mary University of London, and the University of Cambridge, uses a comparatively inexpensive form of genome sequencing to detect signals shared by a range of cancer types.
Publications 10 July 2026

BCI researcher Dr Gabriella Ficz and team have been awarded funding as part of a £5.7m national collaborative initiative exploring how epigenetics can be harnessed to strengthen our immune system’s ability to fight viruses. Dr Ficz will receive £880,000 to support her team’s contribution to the epiPRIME project, awarded by the Advanced Research and Invention Agency (ARIA).
Grants & Awards 25 June 2026

Researchers at Barts Cancer Institute, Queen Mary University of London, have discovered a way in which the environment surrounding triple-negative breast cancer cells helps suppress our immune system, making this cancer harder to treat. The findings open the door to a potential new treatment strategy that could make triple-negative breast cancers more vulnerable to the immune system and help more people to benefit from immunotherapy in future.
Publications 18 June 2026

Professor Louise Jones at Barts Cancer Institute, Queen Mary University of London, has been elected to the Academy of Medical Sciences. She joins 60 exceptional biomedical and health scientists elected to its prestigious Fellowship.
Grants & Awards 21 May 2026

Researchers have developed a new way to understand how genetic changes linked to blood cancer evolve in our cells, offering new insight into predicting blood cancer risk.
Publications 5 May 2026

Researchers have been awarded £1m to launch a new clinical trial for people with myelodysplastic syndromes, a form of blood cancer with limited treatment options.
Publications 8 April 2026

Researchers have developed a way to grow miniature ovarian tumours in the lab that mimic the tumour environment found in patients. The new approach offers a useful way to study how cancer cells interact with the immune system and to explore potential treatments. Ultimately, it could help accelerate progress for patients and reduce reliance on research methods involving animals.
Publications 25 March 2026

Thousands of people with advanced bladder cancer across the UK can now receive three rather than six chemotherapy cycles after research led by Professor Thomas Powles and team leads to a change to NHS treatment guidelines. For patients, this means fewer toxic side effects and a better quality of life during treatment.
Update 12 February 2026

Today, on World Cancer Day, we’re sharing a new film. Join us as we go behind the scenes at Barts Cancer Institute (BCI), Queen Mary University of London and meet the people who are making progress possible.
Video 4 February 2026